What is the typical concentration of mupirocin (Bactroban) ointment used for bacterial skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mupirocin Concentration

Mupirocin is available as a 2% ointment formulation for the treatment of bacterial skin infections. 1

Standard Formulation

  • Mupirocin 2% ointment is the FDA-approved concentration for topical use in treating superficial skin infections 1
  • This 2% formulation is consistently recommended across all major clinical guidelines for both treatment and decolonization purposes 2, 3, 4

Clinical Applications by Concentration

For Skin Infections

  • Apply mupirocin 2% ointment three times daily for impetigo and localized staphylococcal/streptococcal infections 4
  • Treatment duration is typically 5 days for impetigo 4 or 5-10 days for other superficial infections 3
  • Clinical cure or marked improvement occurs in over 90% of patients with bacterial eradication 5, 6

For Nasal Decolonization

  • Use mupirocin 2% ointment (or 2% calcium mupirocin nasal formulation) applied to each nostril twice daily 2
  • For surgical prophylaxis: start at least 48 hours before surgery and continue for 5-7 days total 2
  • For recurrent staph infections: apply twice daily for the first 5 days of each month, which reduces recurrences by approximately 50% 3

Important Formulation Considerations

  • The standard polyethylene glycol-based 2% ointment is for external use only and should not be used on mucosal surfaces 1
  • A paraffin-based formulation (Bactroban Nasal with mupirocin calcium) is specifically available for intranasal use 1
  • No other concentrations (higher or lower than 2%) are clinically used or FDA-approved 1

Key Clinical Caveat

  • Avoid using the polyethylene glycol-based 2% ointment in patients with moderate to severe renal impairment when treating large open wounds, as polyethylene glycol can be absorbed and is renally excreted 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mupirocin for Staph Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Topical Antibiotic Treatment for Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Overview of the role of mupirocin.

The Journal of hospital infection, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.